These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7691147)

  • 1. Immunotyping of blasts in refractory anaemia with excess of blasts.
    Oertel J; Kleiner S; Huhn D
    Br J Haematol; 1993 Jun; 84(2):305-9. PubMed ID: 7691147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD 34 immunotyping of blasts in myelodysplasia.
    Oertel J; Oertel B; Beyer J; Huhn D
    Ann Hematol; 1994 Feb; 68(2):77-80. PubMed ID: 7511934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD34 immunophenotyping of blasts in myelodysplasia.
    Oertel J; Huhn D
    Leuk Lymphoma; 1994 Sep; 15(1-2):65-9. PubMed ID: 7532058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotyping of blasts in human bone marrow.
    Oertel J; Oertel B; Schleicher J; Huhn D
    Ann Hematol; 1996 Mar; 72(3):125-9. PubMed ID: 8766253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute myeloid leukemia with t(6;9) (p23;q34): association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype.
    Alsabeh R; Brynes RK; Slovak ML; Arber DA
    Am J Clin Pathol; 1997 Apr; 107(4):430-7. PubMed ID: 9124211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.
    Bouscary D; De Vos J; Guesnu M; Jondeau K; Viguier F; Melle J; Picard F; Dreyfus F; Fontenay-Roupie M
    Leukemia; 1997 Jun; 11(6):839-45. PubMed ID: 9177438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotype of c-kit cells in normal human bone marrow: implications for the detection of minimal residual disease in AML.
    Macedo A; Orfao A; Martínez A; Vidriales MB; Valverde B; López-Berges MC; San Miguel JF
    Br J Haematol; 1995 Feb; 89(2):338-41. PubMed ID: 7532985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QBEND10 for the diagnosis of myelodysplastic syndromes in routinely processed bone marrow biopsy specimens.
    Horny HP; Wehrmann M; Schlicker HU; Eichstaedt A; Clemens MR; Kaiserling E
    J Clin Pathol; 1995 Apr; 48(4):291-4. PubMed ID: 7542289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of Fas, FasL and Bcl-2 and apoptosis of bone marrow CD34+ cells in patients with myelodysplastic syndrome].
    Zhang Z; Xie J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):274-7. PubMed ID: 12844412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of molecular targets on the surface of CD34+CD38- bone marrow cells in myelodysplastic syndromes.
    Xie W; Wang X; Du W; Liu W; Qin X; Huang S
    Cytometry A; 2010 Sep; 77(9):840-8. PubMed ID: 20662087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD117/CD34 expression in leukemic blasts.
    Wells SJ; Bray RA; Stempora LL; Farhi DC
    Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further investigations on the expression of HLA-DR, CD33 and CD13 surface antigens in purified bone marrow and peripheral blood CD34+ haematopoietic progenitor cells.
    Pierelli L; Teofili L; Menichella G; Rumi C; Paoloni A; Iovino S; Puggioni PL; Leone G; Bizzi B
    Br J Haematol; 1993 May; 84(1):24-30. PubMed ID: 7687858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome.
    Schlesinger M; Silverman LR; Jiang JD; Yagi MJ; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1996; 48(4):149-66. PubMed ID: 9819667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia.
    Huh YO; Jilani I; Estey E; Giles F; Kantarjian H; Freireich E; Albitar M
    Leukemia; 2002 Nov; 16(11):2249-52. PubMed ID: 12399969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy.
    Estey E; Thall P; Beran M; Kantarjian H; Pierce S; Keating M
    Blood; 1997 Oct; 90(8):2969-77. PubMed ID: 9376577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of immunophenotypic features of blasts in patients with myelodysplastic syndrome by flow cytometry and its diagnostic significance].
    Sun JF; Yang B; Zhang L; Huang Y; Yang J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):632-5. PubMed ID: 22739171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of the phenotypic abnormalities of bone marrow cells in childhood myelodysplastic syndromes and juvenile myelomonocytic leukemia.
    Oliveira AF; Tansini A; Vidal DO; Lopes LF; Metze K; Lorand-Metze I
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27748021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunophenotypic profile of myeloid cells in granulocytic sarcoma by immunohistochemistry. Correlation with blast differentiation in bone marrow.
    Chang CC; Eshoa C; Kampalath B; Shidham VB; Perkins S
    Am J Clin Pathol; 2000 Nov; 114(5):807-11. PubMed ID: 11068557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
    Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
    Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced myeloid specificity of CD117 compared with CD13 and CD33.
    Nomdedéu JF; Mateu R; Altès A; Llorente A; Rio C; Estivill C; López O; Ubeda J; Rubiol E
    Leuk Res; 1999 Apr; 23(4):341-7. PubMed ID: 10229319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.